Withdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative?
Open Access
- 27 April 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 81 (4), e57
- https://doi.org/10.1136/annrheumdis-2020-217575
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trialAnnals Of The Rheumatic Diseases, 2019
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2019
- Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceAnnals Of The Rheumatic Diseases, 2016
- Damage in systemic lupus erythematosus and its association with corticosteroidsArthritis & Rheumatism, 2000